Two Novel JAK Inhibitors Show Promise in Ulcerative Colitis ...Middle East

Medscape - News
Ritlecitinib and brepocitinib were both more effective than placebo with acceptable safety in a phase 2b study of patients with moderate to severe ulcerative colitis. Medscape Medical News

Hence then, the article about two novel jak inhibitors show promise in ulcerative colitis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Two Novel JAK Inhibitors Show Promise in Ulcerative Colitis )

Apple Storegoogle play

Last updated :

Also on site :



Latest News